$1.35
-0.08[-5.59%]
At close: Apr 29
$1.35
0[0.00%]
PreMarket: 7:18AM EDT
Context Therapeutics
(NASDAQ:CNTX)Latest News for Context Therapeutics Stock (NASDAQ:CNTX)
Context Therapeutics Stock (NASDAQ: CNTX)
Categories: All
Thursday, March 21, 2024
Friday, January 12, 2024
Friday, December 15, 2023
- Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Dec 15, 2023, 12:46PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Dec 15, 2023, 12:31PM
- Constellation Energy, Battalion Oil And Other Big Stocks Moving Higher On FridayAvi Kapoor - Dec 15, 2023, 10:21AM
Friday, December 08, 2023
Thursday, November 09, 2023
Wednesday, November 01, 2023
Tuesday, October 31, 2023
Monday, October 02, 2023
Wednesday, September 27, 2023
Monday, September 11, 2023
Wednesday, August 09, 2023
Friday, August 04, 2023
Wednesday, July 19, 2023
Thursday, June 08, 2023
Tuesday, June 06, 2023
Monday, June 05, 2023
Thursday, June 01, 2023
Tuesday, May 16, 2023
Wednesday, May 10, 2023
Thursday, May 04, 2023
Wednesday, April 26, 2023
Friday, April 14, 2023
Thursday, March 23, 2023
- Stocks That Hit 52-Week Lows On ThursdayBenzinga Insights - Mar 23, 2023, 1:11PM
- Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2023Benzinga Insights - Mar 23, 2023, 11:00AM
- Context Therapeutics shares are trading lower after the company reported FY22 financial results. Additionally, HC Wainwright & Co. downgraded the stock from Buy to Neutral.Michael Horton - Mar 23, 2023, 10:24AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Mar 23, 2023, 9:06AM
- HC Wainwright & Co. Downgrades Context Therapeutics to NeutralBenzinga Newsdesk - Mar 23, 2023, 6:25AM
Wednesday, March 22, 2023
Wednesday, February 22, 2023
Tuesday, February 14, 2023
Tuesday, February 07, 2023
Monday, February 06, 2023
Wednesday, February 01, 2023
Tuesday, January 31, 2023
- Tesla, Amazon, Apple, Context Therapeutics, Snap: Why These 5 Stocks Are Drawing Investors' Attention TodayBhavik Nair - Jan 31, 2023, 7:55PM
- Dow Surges Over 200 Points; Pfizer Issues Weak ForecastLisa Levin - Jan 31, 2023, 2:36PM
- Why AppTech Payments Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Jan 31, 2023, 1:13PM
- Why Context Therapeutics (CNTX) Shares Are Seeing Blue SkiesHenry Khederian - Jan 31, 2023, 12:44PM
- Dow Turns Higher; Nasdaq Jumps 100 PointsLisa Levin - Jan 31, 2023, 12:20PM
- Context Therapeutics shares are trading higher after the company announced its clinical trial collaborator, Stemline Therapeutics, received approval from the FDA for ORSERDU in ER+, HER2-, ESR1-mutated breast cancer.Benzinga Newsdesk - Jan 31, 2023, 11:14AM
- Context Therapeutics Shares Halted Again On Circuit Breaker To Downside; Up 102%Benzinga Newsdesk - Jan 31, 2023, 9:39AM